Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (800) 227-6666
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G51022-50 | 50 µg | $441 |
Human ANTXR1 / TEM8 Protein (Recombinant Human IgG Fc, C-terminus) (Met1-Ser321) - LS-G51022
Human ANTXR1 / TEM8 Protein (Recombinant Human IgG Fc, C-terminus) (Met1-Ser321) - LS-G51022
Description:
ANTXR1 / TEM8 Protein LS-G51022 is a Recombinant Human ANTXR1 / TEM8 produced in HEK 293 Cells Met1-Ser321 with Human IgG Fc, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
ANTXR1 / TEM8 Protein LS-G51022 is a Recombinant Human ANTXR1 / TEM8 produced in HEK 293 Cells Met1-Ser321 with Human IgG Fc, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Specifications
Type
Recombinant Protein
Target
ANTXR1 / TEM8
Synonyms
ANTXR1 | Tumor endothelial marker 8 | Anthrax toxin receptor 1 | TEM8
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Applications
- Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Tag
Human IgG Fc, C-terminus
Region
Met1-Ser321
Predicted Molecular Weight
The recombinant human ANTXR1 /Fc is a disulfide-linked homodimer. The reduced monomer comprises 530 amino acids and has a predicted molecular mass of 59.4 kDa. The apparent molecular mass of the protein is approximately 69 kDa in SDS-PAGE under reducing conditions.
Expression System
HEK 293 Cells
Source Species
Human
Purification
> 92 % as determined by SDS-PAGE
Bio-Activity
Not Tested
Endotoxin
Less than 1.0 EU/µg protein (determined by LAL method).
Presentation
Lyophilized from sterile PBS, pH 7.4, with 5 % trehalose, 5% mannitol and 0.01% Tween80
Reconstitution
Reconstitute in 200ul of sterile water to a concentration of 0.25mg/ml.
Storage
Aliquot and store at -20°C to -80°C for one year. Avoid repeated freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About ANTXR1 / TEM8
Publications (0)
Customer Reviews (0)
Popular ANTXR1 / TEM8 Proteins
Source:
Human
Tag:
6His, C-terminus
Source:
Yeast
Tag:
6His, N-terminus
Source:
Yeast
Tag:
6His, N-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/4/2024
Date Requested: 11/4/2024
